Abstract:Graphical and Lay Summary A group of photosynthetic microorganisms known as microalgae produces proteins, lipids, antioxidants, and coloring chemicals that are utilized in many industries. However, only in a few cases, like fish farming, the microalgae‐based production of these compounds is competitive with other sources at the current technological level. Recent studies have demonstrated that it is feasible to achieve larger yields by modifying cultivation technology and creating novel microalgae strains, making the production of microalgae more competitive. Microalgae are considered to be a promising group of organisms for fuel production, waste processing, pharmaceutical applications, and as a source of food components. Unicellular algae are worth being considered because of their capacity to produce comparatively large amounts of lipids, proteins, and vitamins while requiring little room for growth. They can also grow on waste and fix CO2 and nitrogen compounds. However, production costs limit the industrial use of microalgae to the most profitable applications including micronutrient production and fish farming. Therefore, novel microalgae based technologies require an increase of the production efficiencies or values. Here we review the recent studies focused on getting strains with novel characteristics or cultivating techniques that improve production's robustness or efficiency and categorize these findings according to the fundamental factors that determine microalgae growth. Improvements of light and nutrient delivery, as well as other aspects of photobioreactor design, have shown the highest average increase in productivity. Other methods, such as an improvement of phosphorus or CO2 fixation and temperature adaptation have been found to be less effective. Furthermore, interactions with particular bacteria may promote the growth of microalgae, although bacterial and grazer contaminations must be managed to avoid culture failure. The competitiveness of the algal products will increase if these discoveries are applied to industrial settings.

Current advances in the algae-made biopharmaceuticals field

Recent advancements in the genetic engineering of microalgae

Microalgae-made vaccines against infectious diseases

Recent advances in microalgal production, harvesting, prediction, optimization, and control strategies

Advances in the Development of Biofertilizers and Biostimulants from Microalgae

Emerging Technologies in Algal Biotechnology: Toward the Establishment of a Sustainable, Algae-Based Bioeconomy

Harnessing genetic engineering to drive economic bioproduct production in algae

Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae

Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses

Recent advances in the bio-application of microalgae-derived biochemical metabolites and development trends of photobioreactor-based culture systems

Recent biotechnological applications of value-added bioactive compounds from microalgae and seaweeds

Microorganism-mediated Algal Biomass Processing for Clean Products Manufacturing: Current Status, Challenges and Future Outlook

Recent advances and fundamentals of microalgae cultivation technology

Macroalgae: Marine players in vaccinology

Emerging Trends in Genetic Engineering of Microalgae for Commercial Applications

Bioprospecting marine microalgae as sustainable bio-factories for value-added compounds

Bioengineering of Microalgae: Recent Advances, Perspectives, and Regulatory Challenges for Industrial Application

The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics

A perspective on the biotechnological potential of microalgae

The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals

Algal biorefinery culminating multiple value-added products: recent advances, emerging trends, opportunities, and challenges